Loan & Debt30 Oct 2026, 05:31 pm
SMS Pharma Lends ₹50 Cr to Subsidiary SMS Peptides
AI Summary
SMS Pharmaceuticals Limited has entered into a loan agreement with its subsidiary, SMS Peptides Private Limited, to provide business funding. The loan facility is up to an aggregate amount not exceeding Rs. 50 Crores (Rupees Fifty Crore Only), to be disbursed in one or more tranches. SMS Pharmaceuticals holds a 99.99% stake in SMS Peptides. The transaction is conducted on an arm's length basis and is classified as an unsecured loan. The agreement was executed on October 30, 2026, with no outstanding loan amount as of the disclosure date.
Key Highlights
- SMS Pharma provides loan facility to subsidiary SMS Peptides.
- Loan amount up to Rs. 50 Crores in multiple tranches.
- SMS Pharma holds 99.99% stake in the subsidiary.
- Transaction is on an arm's length basis.
- Loan is unsecured with execution date of October 30, 2026.
Price Impact
More from SMSPHARMA